Home > Boards > US Listed > Biotechs > Genetic Technologies Ltd. (GENE)

GENE .69 , 2nd IPO was recently priced

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Blutribe Member Profile
 
Followed By 73
Posts 3,997
Boards Moderated 0
Alias Born 08/09/04
160x600 placeholder
Genetic Technologies CEO to Participate in Investor Webinar and Q&A Session on June 24, 2020 GlobeNewswire Inc. - 6/23/2020 8:00:10 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/19/2020 6:05:54 AM
US Patent Office Grants Key Risk Test Patent GlobeNewswire Inc. - 6/18/2020 8:00:10 AM
Genetic Technologies Announces Closing of $8.0 Million Public Offering GlobeNewswire Inc. - 5/28/2020 9:00:10 PM
Genetic Technologies Announces Pricing of $8.0 Million Public Offering GlobeNewswire Inc. - 5/26/2020 9:22:07 AM
Genetic Technologies Provides Operational Update - Successful Prototype Polygenic Risk Score for COVID-19 Created GlobeNewswire Inc. - 5/22/2020 4:05:10 PM
Genetic Technologies - Accelerated development of new COVID-19 Polygenic Risk Test for Risk of Developing Life-Threatening Co... GlobeNewswire Inc. - 5/20/2020 9:15:10 AM
Genetic Technologies Announces Closing of $1.44 Million Registered Direct Offering GlobeNewswire Inc. - 4/23/2020 8:00:10 AM
Genetic Technologies Announces $1.44 Million Registered Direct Offering GlobeNewswire Inc. - 4/20/2020 8:00:10 AM
COVID-19 Testing Capacity at Genetic Technologies Accredited Laboratory GlobeNewswire Inc. - 4/17/2020 8:00:10 AM
Genetic Technologies Announces Closing of $1.8 Million Registered Direct Offering GlobeNewswire Inc. - 4/6/2020 6:00:10 AM
Genetic Technologies Announces $1.8 Million Registered Direct Offering GlobeNewswire Inc. - 4/1/2020 12:45:10 PM
Genetic Technologies Limited Announces Market Update on Sales, Early Test Results and Launch of Consumer Initiated Testing GlobeNewswire Inc. - 4/1/2020 9:00:10 AM
Genetic Technologies Limited Announces Receipt of Delisting Notification Letter from Nasdaq GlobeNewswire Inc. - 3/13/2020 8:15:10 PM
Genetic Technologies to provide Corporate & Strategic Update at 2020 Biotech Showcase GlobeNewswire Inc. - 1/13/2020 9:00:10 AM
20 Medical centers across 8 US states set to offer Breast Cancer Test GlobeNewswire Inc. - 1/7/2020 11:45:10 AM
Genetic Technologies to Hold Investor Webinar and Q&A Session on December 18 GlobeNewswire Inc. - 12/17/2019 9:00:10 AM
Genetype for Breast Cancer commissioned with sales to commence First Quarter 2020 GlobeNewswire Inc. - 12/10/2019 7:00:10 AM
Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report GlobeNewswire Inc. - 11/15/2019 8:30:00 AM
Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming Milestones GlobeNewswire Inc. - 11/5/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/31/2019 8:51:28 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/30/2019 6:13:34 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/28/2019 2:13:12 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/25/2019 12:16:17 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/11/2019 10:54:41 AM
Blutribe   Wednesday, 05/29/19 10:47:49 AM
Re: wesley_ post# 2338
Post # of 2361 
GENE .69 , 2nd IPO was recently priced at .80..so bargain price here :

Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company. GTG offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company’s lead products GeneType for Breast Cancer and ‘GeneType for Colorectal Cancer’ are clinically validated risk assessment tests for non-hereditary breast cancer and are first in class.

Genetic Technologies is developing a pipeline of risk assessment products.

Buy OVERSOLD, sell OVERBOUGHT...Deep Pockets, so when I begin buying, watch out above! TECHNICAL and FUNDAMENTAL trader..
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist